1-3 of 3
Lara Maloney, BA
Close
Sort by
Journal Articles

Phase 1 Dose-Escalation/Expansion Study Of ARRY-614 In Patients With IPSS Low/Int-1 Risk Myelodysplastic Syndromes

Guillermo Garcia-Manero, MD, Mikkael A. Sekeres, MD, MS, Alan F. List, MD, H. Jean Khoury, MD, Anjali Advani, MD, Elias Jabbour, MD, Hagop M Kantarjian, MD, Jeffrey E Lancet, MD, LouAnn Cable, MS, Kari Guthrie, Grant Hogeland, PhD, Mieke Ptaszynski, MD, Lara Maloney, BA, Donald Corson, Rami S. Komrokji, MD
Journal: Blood
Blood (2013) 122 (21): 387.
https://doi.org/10.1182/blood.V122.21.387.387
Published: 2013
Journal Articles

Role of p38 MAPK and Tie2 in the Pathogenesis of MDS and Their Inhibition by Dual Inhibitor ARRY-614.

Shannon L Winski, PhD, LouAnn Cable, MS, Grant Hogeland, PhD, Suzy Brown, M.S., Dan Weaver, PhD, Jenn Garrus, PhD, Susan Rhodes, BS, Lara Maloney, BA, Ann Marie Ptaszynski, MD, H. Jean Khoury, MD, Mikkael A. Sekeres, MD, MS, Rami S. Komrokji, MD, Guillermo Garcia Manero, MD, David Chantry, PhD
Journal: Blood
Blood (2012) 120 (21): 2825.
https://doi.org/10.1182/blood.V120.21.2825.2825
Published: 2012
Journal Articles

Phase 1 Dose-Escalation/Expansion Study of the p38/Tie2 Inhibitor ARRY-614 in Patients with IPSS Low/Int-1 Risk Myelodysplastic Syndromes

Rami S. Komrokji, MD, Alan F. List, MD, H. Jean Khoury, MD, FACP, Jeffrey E. Lancet, MD, Elias Jabbour, Maria C Foudray, RN, Shannon L Winski, PhD, Stacie Bell, PhD, Selena Armistead Rush, BS, Lara Maloney, BA, Ann Marie Ptaszynski, MD, Hagop M. Kantarjian, Guillermo Garcia-Manero
Journal: Blood
Blood (2011) 118 (21): 118.
https://doi.org/10.1182/blood.V118.21.118.118
Published: 2011